Insiders Arcus Biosciences, Inc.

Equities

Delayed Nyse Other stock markets 20:48:05 11/09/2024 BST			5-day change	1st Jan Change
16.89 ^USD	+1.26%		+3.58%	-11.49%

09-04	Transcript : Arcus Biosciences, Inc. Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-04-2024 04:50 PM
08-27	Arcus Biosciences Gets Up to $250 Million Term Loan Facility From Hercules Capital	MT

Sagimet Biosciences Inc. Announces Appointment of Board of Directors	08-01	CI
Arcus Biosciences Insider Sold Shares Worth $1,177,967, According to a Recent SEC Filing	02-29	MT
Arcus Biosciences Insider Sold Shares Worth $543,187, According to a Recent SEC Filing	02-29	MT
Arcus Biosciences Insider Sold Shares Worth $427,166, According to a Recent SEC Filing	26/09/23	MT
Insider Sell: Arcus Biosciences	26/06/23	MT
Insider Sell: Arcus Biosciences	20/03/23	MT
Arcus Biosciences, Inc. Announces Principal Accounting Officer Changes	10/03/23	CI
Insider Sell: Arcus Biosciences	20/09/22	MT
Arcus Biosciences, Inc. Appoints Dimitry S.A. Nuyten as Chief Medical Officer	08/08/22	CI
Insider Sell: Arcus Biosciences	21/06/22	MT
Insider Sell: Arcus Biosciences	21/06/22	MT
Insider Sell: Arcus Biosciences	18/03/22	MT
Insider Sell: Arcus Biosciences	22/12/21	MT
Insider Sell: Arcus Biosciences	20/12/21	MT
Insider Sell: Arcus Biosciences	20/12/21	MT
Insider Sell: Arcus Biosciences	22/09/21	MT
Arcus Biosciences, Inc. Announces Board Changes	11/08/21	CI
Arcus Biosciences, Inc. Appoints Nicole Lambert to the Board as Class II Director	05/08/21	CI
Bill Grossman, Arcus Biosciences, Inc.'s Chief Medical Officer, Resigns	19/07/21	CI
Insider Trends: Arcus Biosciences Insider Sale Scales Back 90-Days of Buys	21/06/21	MT

No results for this search